American Society of Hematology

SHERPA: Blue

People

  1. Tallman
    Tallman
  2. Levine
    Levine
  3. Stein
    Stein
  4. Park
    Park
  5. Abdel-Wahab
    Abdel-Wahab
  6. Devlin
    Devlin
  7. Goldberg
    Goldberg
  8. Famulare
    Famulare
  9. Zhang
    Zhang
  10. Roshal
    Roshal

Groups

  1. Adult Leukemia (301)
  2. Center for Hematologic Malignancies (301)
  3. Department of Medicine (301)
  4. Hematologic Malignancies, Division of (301)
  5. GSK Faculty (90)
  6. Executive Committee, Center for Hematologic Malignancies (86)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (77)
  8. Human Oncology and Pathogenesis Program (76)
  9. Hematology-Oncology Fellows (69)
  10. Weinberg Fellows (61)
Search Within
  1. "Martin Tallman"
Formats
  1. Meeting Abstract (208)
  2. Journal Article (90)
  3. Guidelines (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Adult Leukemia (301)
  2. Center for Hematologic Malignancies (301)
  3. Department of Medicine (301)
  4. Hematologic Malignancies, Division of (301)
  5. GSK Faculty (90)
  6. Executive Committee, Center for Hematologic Malignancies (86)

More Groups

People
  1. Martin Tallman (301)
  2. Ross Levine (72)
  3. Eytan Stein (59)
  4. Jae Park (42)
  5. Omar Abdel-Wahab (39)
  6. Sean Devlin (31)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (10)
  5. 2021 (16)
  6. 2020 (18)

More Years

Publications
  1. Blood (274)
  2. Blood Advances (27)

Results (301)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction
    Journal Article

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912
    Research Letter

    Shanafelt, T. D.; Wang, X. V.; Hanson, C. A.; Paietta, E.; O’Brien, S.; Barrientos, J.; Jelinek, D. F.; Braggio, E.; Leis, J. F.; Zhang, C. C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML
    Meeting Abstract

    Chin, K. K.; Derkach, A.; Famulare, C.; Gupta, G.; Borge, P.; Geyer, M. B.; Goldberg, A. D.; Haque, T.; Park, J. H.; Roeker, L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Addition of blinatumomab to consolidation therapy among older newly diagnosed patients (pts) with BCR::ABL1 negative B-lineage acute lymphoblastic leukemia (ALL) in the ECOG-ACRIN E1910 randomized phase III trial
    Meeting Abstract

    Podoltsev, N. A.; Sun, Z.; Litzow, M. R.; Paietta, E.; Roberts, K. G.; Zhang, Y.; Racevskis, J.; Lazarus, H. M.; Rowe, J. M.; Arber, D. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patients with AML and an IDH2-R172 mutation exhibit a unique response to intensive induction chemotherapy, suggesting futility of mid-cycle bone marrow biopsy and caution when considering re-induction
    Meeting Abstract

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Genetic risk classification for adults with AML receiving less-intensive therapies: The 2024 ELN recommendations
    Journal Article

    Döhner, H.; DiNardo, C. D.; Appelbaum, F. R.; Craddock, C.; Dombret, H.; Ebert, B. L.; Fenaux, P.; Godley, L. A.; Hasserjian, R. P.; Larson, R. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia
    Journal Article

    Koury, L. C. D. A.; Kim, H. T.; Undurraga, M. S.; Navarro-Cabrera, J. R.; Salinas, V.; Muxi, P.; Melo, R. A. M.; Glória, A. B.; Pagnano, K.; Nunes, E. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Ibrutinib-based therapy reinvigorates CD8(+) T cells compared to chemoimmunotherapy: Immune monitoring from the E1912 trial
    Journal Article

    Papazoglou, D.; Wang, X. V.; Shanafelt, T. D.; Lesnick, C. E.; Ioannou, N.; De Rossi, G.; Herter, S.; Bacac, M.; Klein, C.; Tallman, M. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Characteristics and prognostic impact of IDH mutations in AML: A COG, SWOG, and ECOG analysis
    Journal Article

    Zarnegar-Lumley, S.; Alonzo, T. A.; Gerbing, R. B.; Othus, M.; Sun, Z.; Ries, R. E.; Wang, J.; Leonti, A.; Kutny, M. A.; Ostronoff, F.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
    Journal Article

    McCarter, J. G. W.; Nemirovsky, D.; Famulare, C. A.; Farnoud, N.; Mohanty, A. S.; Stone-Molloy, Z. S.; Chervin, J.; Ball, B. J.; Epstein-Peterson, Z. D.; Arcila, M. E.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save